10x Genomics, Inc.
TXG
$61.65
$1.672.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.13% | -9.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.13% | -9.15% | |||
| Cost of Revenue | -13.72% | -15.54% | |||
| Gross Profit | 5.95% | -6.16% | |||
| SG&A Expenses | 18.51% | -9.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.63% | -7.59% | |||
| Operating Income | -34.67% | -8.98% | |||
| Income Before Tax | -45.13% | 15.44% | |||
| Income Tax Expenses | -214.61% | -41.17% | |||
| Earnings from Continuing Operations | -33.12% | 17.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.12% | 17.12% | |||
| EBIT | -34.67% | -8.98% | |||
| EBITDA | -87.49% | -27.13% | |||
| EPS Basic | -31.33% | 17.90% | |||
| Normalized Basic EPS | -68.52% | -3.11% | |||
| EPS Diluted | -33.33% | 17.90% | |||
| Normalized Diluted EPS | -68.52% | -3.11% | |||
| Average Basic Shares Outstanding | 1.32% | 0.95% | |||
| Average Diluted Shares Outstanding | 1.32% | 0.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||